Retrospective study of salazosulfapyridine in eight patients with rheumatoid arthritis on hemodialysis

201316 citationsJournal Article

Authors

If SASP is initiated at a low dosage (≤ 500 mg) and increased up to 1000 mg under careful monitoring, it is safe for HD patients.

Published in: Modern Rheumatology

Volume 24, Issue 2, pp. 285-290

Field-Weighted Citation Impact: 0.99